Boston, MA -- (SBWIRE) -- 08/21/2013 -- Chartpoppers.com Spends all day scouring the markets for the next huge Penny Stock Winner. Chartpoppers.com issues news alert on the following stocks:- SafeStitch Medical Inc (OTCBB:SFES), Cannabis Science Inc (OTCMKTS:CBIS), CHINA CONSTRUCTION B (OTCMKTS:CICHY), Cellceutix Corp (OTCBB:CTIX)
In previous session, SafeStitch Medical Inc (OTCBB:SFES) traded 225,614 shares and the average volume of the stock remained 115,789 shares. The 52 week range of the stock remained $0.21 - $1.49. The stock was a bull and advanced +14.04% while its closing price stayed at $1.30. The market capitalization of the stock remained 80.21 million. The half-yearly trend of the stock remained positive +306.25%.
Is SFES a Solid Investment at These Levels? Read This Report For Details
SafeStitch Medical, Inc., a developmental stage medical device company, engages in the development of medical devices in the United States.
Cannabis Science Inc (OTCMKTS:CBIS) volume of the stock was 1.73 million shares in the most recent session and the average volume remained 1.98 million shares. The stock boosted +2.35% and finished the prior session at the closing price of $0.0480. The market capitalization of the stock remained 31.86 million. The half-yearly trend of the stock remained negative -33.33%.
How Should Investors Trade CBIS Now? Don’t Miss out a Special Trend Analysis
Cannabis Science, Inc., a development stage company, engages in the development, production, and commercialization of phytocannabinoid-based pharmaceutical products.
CHINA CONSTRUCTION B (OTCMKTS:CICHY) traded with volume of 96,881 shares and the average volume of the stock remained 79,979 shares. The stock decreased -2.17% and finished the trading at $14.90. The market capitalization of the stock remained 183.08 billion. The beta of the stock remained 0.97.
What CICHY’s Charts Are Signaling for Traders? Find Out Here
China Construction Bank Corporation, together with its subsidiaries, provides corporate and personal banking, and treasury services.
Cellceutix Corp (OTCBB:CTIX) was a volume gainer of 259,007 shares and the average volume of the stock remained 319,065 shares. The stock opened the session at $1.99 and finished at the end of the day at $1.99 and the stock plunged -0.50%. The market capitalization of the stock remained 185.42 million. The half-yearly trend of the stock remained positive +15.03%.
Should CTIX a Buy or Sell Now? Find Out Here
Cellceutix Corporation, a development stage biopharmaceutical company, engages in the discovery and development of small molecule drugs to treat diseases primarily in the areas of cancer and inflammatory disease.
Chartpoppers.com Spends all day scouring the markets for the next huge Penny Stock Winner. Investors have come to trust us for our up to date commentary on all hot stocks so please visit chartpoppers right now and see what it’s all about for yourself! At 50,000 Visitors a Month and growing rapidly chartpoppers is the hottest thing in Penny Stocks!
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list.
Never invest into a stock discussed on this web site or the ChartPoppers.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
ChartPoppers.com is owned and operated by One22 Media,LLC. We are engaged in the business of advertising and promoting companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. ChartPoppers’s sponsored advertisements do not purport to provide an analysis of any company’s financial position, operations or prospects and this is not to be construed as a recommendation by ChartPoppers or an offer or solicitation to buy or sell any security. Neither the owner of ChartPoppers nor any of its members, officers, directors, contractors or employees is licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters.
Read Full Disclaimer at: http://chartpoppers.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)